1 of 51next Page
Financial Statements

Bayer Group Consolidated Income Statements

[Table 4.1]
Note 2012 2013
€ million € million
Net sales [7] 39,741 40,157
Cost of goods sold (19,070) (19,347)
Gross profit 20,671 20,810
Selling expenses [8] (9,981) (10,080)
Research and development expenses [9] (3,013) (3,190)
General administration expenses (1,866) (1,883)
Other operating income [10] 1,087 897
Other operating expenses [11] (2,970) (1,620)
EBIT* 3,928 4,934
Equity-method loss [13.1] (18) (16)
Financial income 503 389
Financial expenses (1,237) (1,100)
Financial result [13] (752) (727)
Income before income taxes 3,176 4,207
Income taxes [14] (723) (1,021)
Income after income taxes 2,453 3,186
of which attributable to non-controlling interest [15] 50 (3)
of which attributable to Bayer AG stockholders (net income) 2,403 3,189
   
Earnings per share [16]    
Basic 2.91 3.86
Diluted   2.91 3.86
2012 figures restated
*EBIT: earnings before financial result and taxes
1 of 51next Page
Last updated: February 28, 2014  Copyright © Bayer AG
http://www.annualreport2013.bayer.com